Systemic antineutrophil cytoplasmic antibody vasculitis in a patient with chronic lymphocytic leukemia: quite a rare diagnosis.

G. Pamuk,M. S. Uyanık,M. Demi̇r,E. Tekgündüz,B. Turgut,M. Soy

DOI: https://doi.org/10.1016/J.LEUKRES.2006.08.017

2007-08-01

Abstract:

What problem does this paper attempt to address?

MANTLE CELL LYMPHOMA WITH SIMULTANEOUS VASCULITIS-ASSOCIATED CRESCENTIC GLOMERULONEPHRITIS: A CASE REPORT AND REVIEW OF THE LITERATURE

Yang Hao,Zhou Qin,Wang Huiping,Wang Rending,Chen Dajin,Chen Jianghua

DOI: https://doi.org/10.19193/0393-6384_2019_4_309

2019-01-01

Acta medica mediterranea

Abstract:Introduction: The kidney may be the location of first clinical disease manifestation in many systemic disorders such as non-Hodgkin lymphoma and vasculitis. However, finding both of these diseases concurrently in a patient is rare. Although similar immunological factors predispose people these diseases, the mechanism by which both diseases can occur and which is the primary disease remain unaddressed. Case presentation: Here, we present the case of a 74 year-old female who was found to have bilateral axillary lymph node enlargement and renal function impairment on presentation to our institution. After biopsy of the lymph node and kidney, this patient was diagnosed with both mantle cell lymphoma (MCL) and vasculitis-associated crescentic glomerulonephritis. The unique immunohistochemistry of the lymph node and kidney were studied and R-CHOP chemotherapy regimen started after diagnosis. Infiltration of lymphoma cells and abnormal expression of cyclin D1 was found on kidney biopsy. Follow-up at three months showed normalization of patient renal function and almost normal urine testing. The enlarged lymph nodes found by ultrasound had contracted to normal size. Conclusion: This represents the first report of MCL-associated vasculitis kidney impairment. Although the related mechanism requires further investigation, proactive screening for such malignancies is essential in the management of such autoimmune diseases.
An evaluation of MES (2(N-Morpholino)ethanesulfonic acid) and Amberlite IRC-50 as pH buffers for nutrient solution studies.

B. Bugbee,F. Salisbury

DOI: https://doi.org/10.1080/01904168509363369

Journal of Plant Nutrition

Abstract:All buffering agents used to stabilize pH in hydroponic research have disadvantages. Inorganic buffers are absorbed and may become phytotoxic. Solid carbonate salts temporarily mitigate decreasing pH but provide almost no protection against increasing pH, and they alter nutrient absorption. Exchange resins are more effective, but we find that they remove magnesium and manganese from solution. We have tested 2(N-Morpholino)ethanesulfonic acid (MES) as a buffering agent at concentrations of 1 and 10 mol m-3 (1 and 10 mM) with beans, corn, lettuce, tomatoes, and wheat. MES appears to be biologically inert and does not interact significantly with other solution ions. Relative growth rates among controls and MES treatments were nearly identical for each species during the trial period. The pH was stabilized by 1 mol m-3 MES. This buffer warrants further consideration in nutrient research.
Renal pathology of prenatally diagnosed nephrosis.

C. Kaplan,B. Lane,F. Miller,D. Baker,C. Trunca

DOI: https://doi.org/10.3109/15513818509078787

Pediatric Pathology

Abstract:Congenital Finnish nephrosis is a rare autosomal-recessive disorder, usually fatal at an early age. The disease is prenatally detected through elevation of alpha fetoprotein in the amniotic fluid of pregnancies at risk. This originates from fetal proteinuria. Maternal serum alpha fetoprotein reflects amniotic fluid levels. We describe a case of congenital nephrosis diagnosed through maternal serum screening in a low-risk population. The characteristic histology of congenital nephrosis is demonstrated, and evidence of proteinuria by electron microscopy, light microscopy, and immunofluorescence is presented.
Systemic Vasculitis Combined with Membranous Nephropathy

ZHANG Hai-tao,CHEN Hui-ping,CHEN Zheng,HUANG Gao-yuan,DENG Kang-ping,LIU Zhi-hong

DOI: https://doi.org/10.3969/j.issn.1006-298x.2011.01.005

2011-01-01

Abstract:Objective:To investigate the clinical and histological features in systemic vasculitis patients combined with membranous nephropathy.Methodology:The clinical data and histological features of four patients in hospital were analyzed.Results:They were three males and one female with the age of 39 to 73 years old.All of them were in accord with the diagnosis of systemic vasculitis.Among them,2 cases were serum MPO-ANCA and P-ANCA positive,and 2 cases were as rapidly progressive glomerulonephritis.All patients had nephrotic syndrome(3 had massive proteinuria)except for large micro-hematuria.3 had elevated serum creatinine(SCr).Renal biopsy specimen revealed necrotizing glomerulonephritis with crescent formation,and subepithelial electron-dense deposits were detected by electron microscopy.Subtype IgG analysis prefered the secondary membranous glomerulonephropathy.2 patients had significantly improvement of hematuria and ANCA titer with immunosuppressive therapy.But those who didn't receive active treatment,1 had increased SCr and 1 entered ESRD.Conclusion:Systemic vasculitis with membranous nephropathy was rare coincidence.The diagnosis depended on renal biopsy.
Anti-Tubular Basement Membrane Antibody Nephritis Manifesting in a Patient With Chronic Lymphocytic Leukemia: A Very Rare Case Report

Niloufar Ebrahimi,Behzad Najafian,Yan Chen Wongworawat,Sayna Norouzi,Amir Abdipour

DOI: https://doi.org/10.1177/23247096241281612

Abstract:Anti-tubular basement membrane (anti-TBM) antibody nephritis is a rare type of tubulointerstitial nephritis associated with progressive decline in kidney function. It is characterized histopathologically by tubular atrophy and dilation, interstitial fibrosis, lymphocyte and macrophage-predominant cellular infiltration, and linear deposition of IgG and complement along the tubular basement membrane. We herein present a case of a 69-year-old male who was recently diagnosed with chronic lymphocytic leukemia (CLL) and was referred for evaluation of kidney failure, ultimately diagnosed as anti-TBM antibody nephritis progressing into end-stage kidney disease (ESKD). This case report highlights the management challenges of anti-TBM antibody nephritis as a rare kidney disorder.
Effects of croton oil on epidermal growth regulators (chalones).

R. Rohrbach,O. Iversen,K. Elgjo,U. Riede,W. Sandritter

DOI: https://doi.org/10.1016/S0005-8165(76)80002-9

Beiträge zur Pathologie

Abstract:
Membranoproliferative Glomerulonephritis In Castleman'S Disease: A Systematic Review Of The Literature And 2 Case Reports

Haoyuan Zhang,Rending Wang,Huiping Wang,Ying Xu,Jianghua Chen

DOI: https://doi.org/10.2169/internalmedicine.51.6298

2012-01-01

Internal Medicine

Abstract:We report two cases of membranoproliferative glomerulonephritis, involved in Castleman's disease of hyaline vascular variant and mixed variant, respectively. The diagnoses were confirmed by cervical lymph node and renal biopsy. Both cases were sensitive to chemotherapy with cyclophosphamide, vindesine and prednisone (COP). With the experience from treating case 1, which was misdiagnosed 9 years previously, we followed a more vigilant approach toward case 2 and achieved a more timely diagnosis. Finally, we reviewed pertinent literature of diagnosis and therapy to facilitate an early diagnosis of rare cases in the future.
Systemic Lupus Erythematosus (SLE) with Acute Nephritis, Antineutrophil Cytoplasmic Antibody- (ANCA-) Associated Vasculitis, and Thrombotic Thrombocytopenic Purpura (TTP): A Rare Case Report with Literature Review

Sohail Farshad,Christopher Kanaan,Solomiia Savedchuk,Dillon S Karmo,Alexandra Halalau,Abhishek Swami

DOI: https://doi.org/10.1155/2019/8750306

2019-12-14

Abstract:Thrombotic thrombocytopenic purpura (TTP) is a potentially fatal disorder that requires urgent identification and treatment. The association of TTP with systemic lupus erythematosus (SLE) and vasculitis has been reported, however, never simultaneously. A 33-year-old woman with a history of SLE presented with acute abdominal pain, fever, arthralgias, and skin rash. She had acute severe hypertension, diffuse abdominal tenderness, and petechial rash. Diagnostic work-up revealed active urine sediment with proteinuria and hematuria and elevated creatinine, anemia, and thrombocytopenia. She was diagnosed with acute lupus nephritis and early microangiopathic hemolytic anemia in the setting of hypertensive urgency and started on intravenous methylprednisolone 500 mg once a day. Within 48 hours, she developed shock with multiorgan dysfunction and succumbed to her illness. Laboratory tests later showed ADAMTS13 activity less than 10% consistent with TTP and p-antineutrophil cytoplasmic antibody (ANCA) positivity. Autopsy revealed small-vessel vasculitis of the visceral organs. Kidney biopsy demonstrated diffuse proliferative glomerulonephritis. This case illustrates the occurrence of SLE nephritis, p-ANCA vasculitis, and severe TTP with rapidly fatal course, and the importance of having a low threshold for initiating plasma exchange therapy. Here, we discuss the case and provide a literature review on cases of TTP with SLE and vasculitis.
A rare adverse event of atorvastatin inducing leukocytoclastic vasculitis with ANCA‐negative (Anti‐Neutrophil cytoplasmic antibody) case report and literature review

Nehemias Guevara‐Rodriguez,Mailing Flores‐Chang,Akhila Chilakala,Jose Contreras,Paula Perdomo,Gandrabur Liliya

DOI: https://doi.org/10.1002/ccr3.7030

2023-03-01

Clinical Case Reports

Abstract:Leukocytoclastic vasculitis is an entity associated with drugs, infections, cryoglobulinemia, and connective tissue diseases but can also be idiopathic, systemic, or organ localized. Moreover, LCV associated with drugs is a rare disorder. When it is present usually has an elevation of anti-neutrophil cytoplasmic antibody, most likely anti-myeloperoxidase, which can be helpful to orient the diagnosis. We are presenting a 55-year-old female with a past medical history of diabetes mellitus (DM) and hyperlipidemia (HLD) who presented with a painful and pruritic rash localized in the abdomen and lower extremities that started 1 week after initiated atorvastatin for management of hyperlipidemia. This is the first case ever reported of leukocytoclastic vasculitis ANCA negative associated with atorvastatin, to our best knowledge.
Unusual presentations in systemic lupus erythematosus with concurrent IgA nephropathy lesion: a rare case report from Eastern Nepal

Popular Pokhrel,Nitesh Neupane,Nitesh Kumar Karna,Gopal Pokhrel,Niraj Chapagain,Abhas Niraula,Ajay Kumar Yadav

DOI: https://doi.org/10.1097/MS9.0000000000002401

2024-07-23

Abstract:Introduction: Systemic lupus erythematosus (SLE) is an autoimmune disease involving multiple organs. While lupus nephritis (LN) is seen in SLE, concurrent IgA nephropathy lesion is rare. Uncommon manifestations like cutaneous ulcers and orbital involvement present diagnostic challenges, and this case from Nepal emphasizes careful diagnostic approach in such cases. Case presentation: A 42-year-old female presented with bilateral lower limb swelling, gum bleeding, and epistaxis. Initial evaluation revealed pancytopenia and suspected renal involvement. Renal biopsy showed IgA nephropathy lesions, but clinical and laboratory findings favored lupus nephritis. Treatment with immunosuppressive agents was initiated. Despite therapy, the patient developed cutaneous ulcers and orbital cellulitis. Decreasing anti-ds DNA levels were noted during the course of treatment. Discussion: The diagnosis of lupus nephritis in the presence of IgA nephropathy lesions emphasizes the complexity of SLE diagnosis. Treatment with immunosuppressive agents targeting the underlying autoimmune process, yet the development of cutaneous ulcers and orbital cellulitis highlights the importance of timely intervention in managing SLE complications. In resource-limited settings, clinicians should initiate interventions based on clinical and lab findings while awaiting detailed biopsy results. Conclusion: This case highlights diagnostic challenges in SLE and emphasizes the necessity for careful monitoring and timely intervention in managing complications. The interplay between SLE and IgA Nephropathy (IgAN) suggests that SLE may trigger or exacerbate it, complicating disease management. Further exploration is needed to enhance the understanding and management of complex autoimmune disorders like SLE.
Type Ⅴ lupus nephritis with anti-neutrophil cytoplasmic antibody associated vasculitis

Xi YANG,Yongchun GE,Zhen CHENG,Zhihong LIU

2015-01-01

Abstract:A 40?years?old woman was characterized by gross hematuria, emaciation and rapidly progressive glomerulonephritis. Her serum MPO?ANCA was positive and a variety of autoantibodies ( ANA, SM, A?beta 2?GP1) were also positive, complement C3 decreased and Coombs? test was positive. Renal biopsy showed crescentic glomerulonephritis with membranous nephropathy. The diagnosis was type V lupus with ANCA associated vasculitis. After treatment of methylprednisolone pulse therapy and plasma exchange, the serum creatinine returned to normal and MPO?ANCA and ANA titer decreased.
Diagnosing and Managing Clinically Silent Lupus Nephritis and Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome: A Clinical Challange

Aqsa Ashraf,Jordan Daloya,Vishal Rana,Aitezaz Ahmed,Alan Kaell

DOI: https://doi.org/10.7759/cureus.24624

2022-04-30

Cureus

Abstract:Lupus nephritis is typically associated with anti-nuclear antibodies and anti-double-stranded DNA antibodies resulting in the intrarenal immune complex deposition. Levels of anti-double-stranded DNA antibodies reflect disease activity in these patients. With negative anti-double-stranded DNA antibodies, establishing a diagnosis of lupus nephritis is difficult. Lupus nephritis overlapped with anti-neutrophil cytoplasmic antibody-associated vasculitis is both a diagnostic and therapeutic dilemma. Herein, we describe a case of an asymptomatic 41-year-old female who had incidental findings of low hemoglobin and elevated serum creatinine. Making a clinical diagnosis of lupus nephritis and anti-neutrophil cytoplasmic antibody-associated vasculitis in an asymptomatic patient can be challenging and must be made based on the interpretation of evolving serology, imaging studies, and histopathology. Based on extensive workup, the patient was diagnosed with concurrent lupus nephritis and anti-neutrophil cytoplasmic antibody-associated vasculitis overlap syndrome warranting immediate immunosuppressive therapy.
Rare CT Findings of Antineutrophil Cytoplasmic Antibody Associated Pulmonary Vasculitis

ZHANG Xiaowei,LIU Jingzhe,LUO Chaofeng,LIU Dong,ZHANG Yongchun,PAN Jishu

DOI: https://doi.org/10.3969/j.issn.1005-5185.2013.09.020

2013-01-01

Abstract:Purpose To explore the rare CT findings of antineutrophil cytoplasmic antibody(ANCA) associated pulmonary vasculitis. Materials and Methods The high resolution CT fndings of 37 patients with ANCA associated pulmonary vasculitis were retrospectively analyzed. Results In 37 patients, 18 cases were Wegener's granulomatosis(WG), 9 cases were Churg-Strauss syndrome(CSS), 10 cases were microscopicpolyangiitis(MPA). In 18 cases of WG, 1 case show ED only lymphatic lungs pulmonary vascular bundle thickening, 17 cases had 1 to 11 nodules with clear edge. 5 cases of CSS appeared ground-glass opacities. In 10 cases of MPA, 1 case showed display shell like reversed halo sign, 9 cases showed patchy exudation, ground-glass opacity and consolidation at part of lesions. Conclusion CT fndings of ANCA associated pulmonary vasculitis are diverse,understanding its rare CT findings and combining laboratory examination can avoid misdiagnosis.
C3 glomerulonephritis and systemic lupus erythematosus: A report of a patient treated with eculizumab and review of the literature

Ruth Fernandez-Ruiz,Rebecca B Blank,Ming Wu,H Michael Belmont

DOI: https://doi.org/10.1177/09612033211027938

IF: 2.858

2021-07-01

Lupus

Abstract:Introduction Activation of the complement pathway by immune complexes is a key feature of systemic lupus erythematosus (SLE) and SLE glomerulonephritis, which translates into low levels of C3 and C4 during active disease. C3 glomerulonephritis (C3GN) is part of a broader group of rare renal diseases, the C3 glomerulopathies, characterized by prominent C3 accumulation in the glomeruli with minimal to no immunoglobulin (Ig) deposition secondary to dysregulation of the alternative pathway of the complement system. Distinguishing lupus nephritis from other complement-mediated kidney disorders, including C3GN, represents a diagnostic challenge with potential therapeutic implications. Methods We report an unusual case of a 55-year-old woman with SLE and previous biopsy-proven class IV lupus nephritis, subsequently diagnosed with C3GN. Furthermore, we review the available literature published from January 2010—March 2021 on the clinical features and management of C3GN in the setting of SLE. Results In addition to our case, very few reports exist in the literature regarding C3GN in association with SLE. The underlying pathogenic mechanism of C3GN consists of dysregulation of the alternative pathway of the complement system, either due to genetic variation in complement-related genes or to acquired autoantibodies targeting C3 or C5 convertases; the latter mechanism could explain the occurrence of C3GN in the setting of autoimmune diseases, although it was not definitively identified in our patient or others with SLE. Similar to some of the previous reports, after suboptimal renal response on mycophenolate mofetil and rituximab, our patient has been successfully treated with eculizumab, thus far with >50% improvement in proteinuria. Conclusions C3GN represents an additional mechanism of renal injury in SLE mediated by alternative complement pathway dysregulation. Although rare, patients with SLE and persistent proteinuria with very low C3 would benefit from expedited renal biopsy to evaluate for C3GN as well as genetic testing, since this entity could require a different therapeutic approach.

rheumatology
Rituximab-induced leukocytoclastic vasculitis in a patient with low-grade orbital B-cell lymphoma: a case report

Nesime İnci Güner,Ömer Dizdar,Alev Türker,Aygin Bayraktar-Ekincioglu

DOI: https://doi.org/10.1097/CAD.0000000000001638

2024-10-01

Abstract:Rituximab is an anti-CD20 chimeric murine/human mAb mainly used to treat certain types of lymphoproliferative malignancies and autoimmune diseases. Although it has been used in the treatment of vasculitis in recent years, it rarely triggers severe vascular skin reactions such as leukocytoclastic vasculitis (LCV). Physicians should be aware of this rare adverse event that requires discontinuation of rituximab, which can occur days or even weeks after rituximab treatment. Here, we report a case of LCV observed in a patient with low-grade orbital B-cell lymphoma treated with weekly rituximab and local radiotherapy. In our case, discontinuation of rituximab and initiation of oral methylprednisolone therapy were sufficient to achieve complete resolution of the LCV.
Chronic neutrophilic leukemia with an associated V617F JAK2 tyrosine kinase mutation

Donald P Mc Lornan,Melanie J Percy,Amy V Jones,Nicholas C P Cross,Mary Frances Mc Mullin

Haematologica

Abstract:Chronic neutrophilic leukemia (CNL) is a rare disease and can cause considerable diagnostic difficulty. Although the V617F JAK2 mutation has been described by several groups to be associated with classical myeloproliferative disorders (MPD), this same mutation has been detected with a low incidence in atypical MPD, such as CNL. Here we report the presence of the V617F mutation in a CNL patient, who is unusual for having survived for more than 96 months, with little disease progression. It remains to be established what role this mutation, which gives cells a proliferative advantage, might play in the pathogenesis and prognosis of rare atypical MPD.
Severe Recalcitrant Necrotizing Leucocytoclastic Vasculitis in Non-Hodgkin's Lymphoma Associated with Hepatitis C: Successful Treatment with the Combination of Antiviral and Immunosuppressive Therapy

Wei Zou,Alexander Kreuter,Renate Schlottmann,Uta Bartke,Peter Altmeyer,Nan Ping Wu,Norbert Brockmeyer

DOI: https://doi.org/10.1080/00015550310007274

2003-01-01

Abstract:Sir, Leucocytoclastic vasculitis (LV) is a common disorder of small dermal vessels characterized by a polymorphonuclear infiltrate and ‘nuclear dust’ as well as fibrinoid change. The clinical presentation may be purely urticarial, purpuric or necrotic (1). The sexes are affected equally, the disorder occurs at all ages and some patients with LV have infections and malignant diseases. Here we report a severe recalcitrant necrotizing LV in a patient with non-Hodgkin’s lymphoma and hepatitis C infection. The LV was successfully treated with a combination of antiviral and immunosuppressive therapy.
Clinical Manifestations of Leukocytoclastic Vasculitis, Treatment, and Outcome in Patients with Ulcerative Colitis: A Systematic Review of the Literature

Ivana Pantic,Djordje Jevtic,Charles W. Nordstrom,Cristian Madrid,Tamara Milovanovic,Igor Dumic

DOI: https://doi.org/10.3390/jcm11030739

IF: 3.9

2022-01-29

Journal of Clinical Medicine

Abstract:Leukocytoclastic vasculitis (LCV) is a rare extraintestinal manifestation (EIM) of ulcerative colitis (UC). Observations about its association with UC stem from case reports and small case series. Due to its rarity, more rigorous cross-sectional studies are scarce and difficult to conduct. The aim of this systematic review was to synthetize the knowledge on this association by reviewing published literature in the form of both case reports and case series; and report the findings according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. In contrast to LCV in Chron disease (CD), which occurs secondary to biologic therapies used for its treatment, LCV in UC is a true reactive skin manifestation. Both genders are equally affected. Palpable purpura (41%) and erythematous plaques (27%) are the most common clinical manifestations. In 41% of patients, the rash is painful, and the lower extremities are most commonly involved (73%). Systemic symptoms such as fever, arthralgias, fatigue, and malaise are seen in 60% of patients. Unlike previous reports, we found that LCV more commonly occurs after the UC diagnosis (59%), and 68% of patients have active intestinal disease at the time of LCV diagnosis. Antineutrophil cytoplasmic antibody (ANCA) is positive in 41% of patients, and 36% of patients have other EIMs present concomitantly with LCV. The majority of patients were treated with corticosteroids (77%), and two (10%) required colectomy to control UC and LCV symptoms. Aside from one patient who died from unrelated causes, all others survived with their rash typically resolving without scarring (82%).

medicine, general & internal
Concurrent existence of cold agglutinin disease and ANCA-associated vasculitis with fulminant pulmonary-renal syndrome poses significant treatment challenges

Moritz Schanz,Benedikt Wagner,Raffi Bekeredjian,Joerg Latus

DOI: https://doi.org/10.1136/bcr-2023-257859

2024-07-29

Abstract:We present a case of a man in his 40s with pulmonary-renal syndrome due to myeloperoxidase-positive antineutrophil cytoplasmic antibodies-associated vasculitis and concurrent cold agglutinin disease, a combination that has not yet been described in the literature. The fulminant course of the disease, including the need for kidney replacement therapy and mechanical ventilation posed a significant treatment challenge due to haemolytic complications.
Use of administrative data for surgical site infection surveillance after congenital cardiac surgery results in inaccurate reporting of surgical site infection rates.

Krista D Atchley,Janine M. Pappas,A. Kennedy,Susan E. Coffin,Jeffrey S. Gerber,Stephanie M. Fuller,T. Spray,K. McCardle,J. Gaynor

DOI: https://doi.org/10.1016/j.athoracsur.2013.08.076

2014-02-01

Abstract:

Systemic antineutrophil cytoplasmic antibody vasculitis in a patient with chronic lymphocytic leukemia: quite a rare diagnosis.

MANTLE CELL LYMPHOMA WITH SIMULTANEOUS VASCULITIS-ASSOCIATED CRESCENTIC GLOMERULONEPHRITIS: A CASE REPORT AND REVIEW OF THE LITERATURE

An evaluation of MES (2(N-Morpholino)ethanesulfonic acid) and Amberlite IRC-50 as pH buffers for nutrient solution studies.

Renal pathology of prenatally diagnosed nephrosis.

Systemic Vasculitis Combined with Membranous Nephropathy

Anti-Tubular Basement Membrane Antibody Nephritis Manifesting in a Patient With Chronic Lymphocytic Leukemia: A Very Rare Case Report

Effects of croton oil on epidermal growth regulators (chalones).

Membranoproliferative Glomerulonephritis In Castleman'S Disease: A Systematic Review Of The Literature And 2 Case Reports

Systemic Lupus Erythematosus (SLE) with Acute Nephritis, Antineutrophil Cytoplasmic Antibody- (ANCA-) Associated Vasculitis, and Thrombotic Thrombocytopenic Purpura (TTP): A Rare Case Report with Literature Review

A rare adverse event of atorvastatin inducing leukocytoclastic vasculitis with ANCA‐negative (Anti‐Neutrophil cytoplasmic antibody) case report and literature review

Unusual presentations in systemic lupus erythematosus with concurrent IgA nephropathy lesion: a rare case report from Eastern Nepal

Type Ⅴ lupus nephritis with anti-neutrophil cytoplasmic antibody associated vasculitis

Diagnosing and Managing Clinically Silent Lupus Nephritis and Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome: A Clinical Challange

Rare CT Findings of Antineutrophil Cytoplasmic Antibody Associated Pulmonary Vasculitis

C3 glomerulonephritis and systemic lupus erythematosus: A report of a patient treated with eculizumab and review of the literature

Rituximab-induced leukocytoclastic vasculitis in a patient with low-grade orbital B-cell lymphoma: a case report

Chronic neutrophilic leukemia with an associated V617F JAK2 tyrosine kinase mutation

Severe Recalcitrant Necrotizing Leucocytoclastic Vasculitis in Non-Hodgkin's Lymphoma Associated with Hepatitis C: Successful Treatment with the Combination of Antiviral and Immunosuppressive Therapy

Clinical Manifestations of Leukocytoclastic Vasculitis, Treatment, and Outcome in Patients with Ulcerative Colitis: A Systematic Review of the Literature

Concurrent existence of cold agglutinin disease and ANCA-associated vasculitis with fulminant pulmonary-renal syndrome poses significant treatment challenges

Use of administrative data for surgical site infection surveillance after congenital cardiac surgery results in inaccurate reporting of surgical site infection rates.